A novel synthetic lipopeptide is allergy-protective by the induction of LPS-tolerance

Clinical and Experimental Allergy

Volumn 43, Issue 7, 2013, Pages 785-797

  Stiehm, M ^a   Peters, K ^a   Wiesmuller K H ^b   Bufe, A ^a   Peters, M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b EMC MICROCOLLECTIONS GMBH   (Germany)

Author keywords

Asthma; Farming environment; Murine models

Indexed keywords

ALUMINUM POTASSIUM SULFATE; HETERODIMER; IMMUNOGLOBULIN E; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPEPTIDE; LIPOPEPTIDE GERD; LIPOPOLYSACCHARIDE; MESSENGER RNA; SYNTHETIC PEPTIDE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BACILLUS CEREUS; BONE MARROW; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DOSE COMPARISON; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTECTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; UPREGULATION;

ANIMALS; ASTHMA; BACILLUS CEREUS; BACTERIAL PROTEINS; BONE MARROW CELLS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE TOLERANCE; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2;

EID: 84879540211     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12116     Document Type: Article

References (50)

1. Riedler J, Braun-Fahrländer C, Eder W et al. ALEX Study Team. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001; 358:1129-33.
2. Braun-Fahrländer C, Riedler J, Herz U et al. Allergy and Endotoxin Study Team. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-77.
3. van Strien RT, Engel R, Holst O et al. ALEX Study Team. Microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and its association with respiratory health. J Allergy Clin Immunol 2004; 113:860-86.
4. Von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Böhm O, von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy 2000; 30:187-93.
5. Peters M, Kauth M, Schwarze J et al. Inhalation of stable dust extract prevents allergen induced airway inflammation and hyperresponsiveness. Thorax 2006; 61:134-9.
6. Peters M, Kauth M, Scherner O et al. Arabinogalactan isolated from cowshed dust extract protects mice from allergic airway inflammation and sensitization. J Allergy Clin Immunol 2010; 126:648-56.
7. Vogel K, Blümer N, Korthals M et al. Animal shed Bacillus licheniformis spores possess allergy-protective as well as inflammatory properties. J Allergy Clin Immunol 2008; 122:307-12.
8. Gerhold K, Blümchen K, Bock A et al. Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 2002; 110:110-6.
9. Gerhold K, Bluemchen K, Franke A, Stock P, Hamelmann E. Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol 2003; 112:389-96.
10. Taylor RC, Richmond P, Upham JW. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol 2006; 117:1148-54.
11. Goldman M. Translational mini-review series on Toll-like receptors: toll-like receptor ligands as novel pharmaceuticals for allergic disorders. Clin Exp Immunol 2007; 147:208-16.
12. Fuchs B, Braun A. Modulation of asthma and allergy by addressing toll-like receptor. J Occup Med Toxicol 2008; 3:S5.
13. Imanishi T, Hara H, Suzuki S, Suzuki N, Akira S, Saito T. Cutting edge: TLR2 directly triggers Th1 effector functions. J Immunol 2007; 178:6715-9.
14. Rylander R, Bake B, Fischer JJ, Helander IM. Pulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 1989; 140:981-6.
15. Lauener RP, Birchler T, Adamski J et al. ALEX study group. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002; 360:465-6.
16. Kobayashi K, Hernandez LD, Galán JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110:191-202.
17. Peters M, Dudziak K, Stiehm M, Bufe A. T-cell polarization depends on concentration of the danger signal used to activate dendritic cells. Immunol Cell Biol 2010; 88:537-44.
18. Debarry J, Garn H, Hanuszkiewicz A et al. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol 2007; 119:1514-21.
19. Crielly EM, Logan NA, Anderton A. Studies on the Bacillus flora of milk and milk products. J Appl Bacteriol 1994; 77:256-63.
20. Coorevits A, De Jonghe V, Vandroemme J et al. Comparative analysis of the diversity of aerobic spore-forming bacteria in raw milk from organic and conventional dairy farms. Syst Appl Microbiol 2008; 31:126-40.
21. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106:551-9.
22. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196:1645-51.
23. Willart MA, Hammad H. Alarming dendritic cells for allergic sensitization. Allergol Int 2010; 59:95-103.
24. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009; 30:475-87.
25. Buckley JM, Wang JH, Redmond HP. Cellular reprogramming by gram-positive bacterial components: a review. J Leukoc Biol 2006; 80:731-41.
26. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 2003; 100:171-94.
27. Wang JH, Doyle M, Manning BJ et al. Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J Immunol 2003; 170:14-8.
28. Gorelik L, Kauth M, Gehlhar K, Bufe A, Holst O, Peters M. Modulation of dendritic cell function by cowshed dust extract. Innate Immun 2008; 14:345-55.
29. Eder W, Klimecki W, Yu L et al. ALEX Study Team. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113:482-8.
30. Patel M, Xu D, Kewin P et al. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 2005; 174:7558-63.
31. Lombardi V, Van Overtvelt L, Horiot S et al. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy 2008; 38:1819-29.
32. Page K, Ledford JR, Zhou P, Wills-Karp M. A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice. Immunol 2009; 183:3400-8.
33. Tulić MK, Wale JL, Holt PG, Sly PD. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000; 22:604-12.
34. Borchers MT, Crosby J, Justice P et al. Intrinsic AHR in IL-5 transgenic mice is dependent on CD4(+) cells and CD49d-mediated signaling. Am J Physiol Lung Cell Mol Physiol 2001; 281:653-9.
35. Levitt RC, McLane MP, MacDonald D et al. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol 1999; 103:485-91.
36. Kenedi E, Laburn H, Mitchell D, Ross FP. On the pyrogenic action of intravenous lipid A in rabbits. J Physiol 1982; 328:361-70.
37. Biswas SK, Bist P, Dhillon MK et al. Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol 2007; 179:4083-92.
38. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002; 4:903-14.
39. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 2006; 10:233.
40. del Fresno C, García-Rio F, Gómez-Piña V et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009; 182:6494-507. Erratum in: J Immunol 2009; 183:2194.
41. Matsushita H, Ohta S, Shiraishi H et al. Endotoxin tolerance attenuates airway allergic inflammation in model mice by suppression of the T-cell stimulatory effect of dendritic cells. Int Immunol 2010; 22:739-47.
42. Dobrovolskaia MA, Medvedev AE, Thomas KE et al. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol 2003; 170:508-19.
43. Deiters U, Gumenscheimer M, Galanos C, Mühlradt PF. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses. Infect Immun 2003; 71:4456-62.
44. Sato S, Nomura F, Kawai T et al. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 2000; 165:7096-101.
45. Yanagawa Y, Onoé K. Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation. J Immunol 2007; 178:6173-80.
46. Henry E, Desmet CJ, Garzé V et al. Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J Immunol 2008; 181:7230-42.
47. Braga M, Quecchia C, Cavallucci E et al. T regulatory cells in allergy. Int J Immunopathol Pharmacol 2011; 24:55S-64S.
48. Lu M, Dawicki W, Zhang X, Huang H, Nayyar A, Gordon JR. Therapeutic induction of tolerance by IL-10-differentiated dendritic cells in a mouse model of house dust mite-asthma. Allergy 2011; 66:612-20.
49. von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol 2010; 10:861-8.
50. Brand S, Teich R, Dicke T et al. Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes. J Allergy Clin Immunol 2011; 128:618-25.